Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The Other Vaccines market in Hong Kong has been growing steadily in recent years, driven by various factors such as customer preferences, local special circumstances, and underlying macroeconomic factors.
Customer preferences: Hong Kong citizens are becoming more health-conscious, which has led to an increased demand for vaccines. Additionally, there has been a growing awareness of the importance of preventative healthcare, which has further boosted demand for vaccines. The COVID-19 pandemic has also had an impact on customer preferences, with many people seeking to protect themselves from infectious diseases.
Trends in the market: The Other Vaccines market in Hong Kong has been growing steadily, with a particular focus on vaccines for infectious diseases such as influenza, hepatitis, and pneumococcal disease. There has also been an increasing demand for travel vaccines, as more people travel overseas for work and leisure. In recent years, there has been a trend towards the use of combination vaccines, which offer protection against multiple diseases in a single shot.
Local special circumstances: Hong Kong is a densely populated city with a high degree of international connectivity, which makes it particularly vulnerable to the spread of infectious diseases. This has led to a strong emphasis on preventative healthcare, including vaccination programs. Additionally, Hong Kong has a large population of elderly citizens, who are particularly susceptible to infectious diseases and are therefore a key target market for vaccines.
Underlying macroeconomic factors: Hong Kong has a strong and stable economy, with a high level of healthcare expenditure. This has created a favorable environment for the development and distribution of vaccines. Additionally, Hong Kong has a well-established healthcare system, which has helped to facilitate the growth of the Other Vaccines market. The government has also been supportive of vaccination programs, which has further boosted demand for vaccines.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
